107 related articles for article (PubMed ID: 3427266)
1. Investigation of the antinociceptive activity of buprenorphine in sheep.
Nolan A; Livingston A; Waterman AE
Br J Pharmacol; 1987 Nov; 92(3):527-33. PubMed ID: 3427266
[TBL] [Abstract][Full Text] [Related]
2. Further studies on the antinociceptive activity and respiratory effects of buprenorphine in sheep.
Waterman AE; Livingston A; Amin A
J Vet Pharmacol Ther; 1991 Sep; 14(3):230-4. PubMed ID: 1744931
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic and pharmacodynamic modelling after subcutaneous, intravenous and buccal administration of a high-concentration formulation of buprenorphine in conscious cats.
Doodnaught GM; Monteiro BP; Benito J; Edge D; Beaudry F; Pelligand L; Steagall P
PLoS One; 2017; 12(4):e0176443. PubMed ID: 28445495
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and pharmacodynamic modelling of intravenous, intramuscular and subcutaneous buprenorphine in conscious cats.
Steagall PV; Pelligand L; Giordano T; Auberger C; Sear JW; Luna SP; Taylor PM
Vet Anaesth Analg; 2013 Jan; 40(1):83-95. PubMed ID: 22998333
[TBL] [Abstract][Full Text] [Related]
5. PK-PD modeling of buprenorphine in cats: intravenous and oral transmucosal administration.
Robertson SA; Lascelles BD; Taylor PM; Sear JW
J Vet Pharmacol Ther; 2005 Oct; 28(5):453-60. PubMed ID: 16207308
[TBL] [Abstract][Full Text] [Related]
6. Dose-related antinociceptive effects of intravenous buprenorphine in cats.
Steagall PV; Mantovani FB; Taylor PM; Dixon MJ; Luna SP
Vet J; 2009 Nov; 182(2):203-9. PubMed ID: 18691917
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic-pharmacodynamic modelling of intravenous buprenorphine in conscious horses.
Love EJ; Pelligand L; Taylor PM; Murrell JC; Sear JW
Vet Anaesth Analg; 2015 Jan; 42(1):17-29. PubMed ID: 24735059
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover study.
Escher M; Daali Y; Chabert J; Hopfgartner G; Dayer P; Desmeules J
Clin Ther; 2007 Aug; 29(8):1620-31. PubMed ID: 17919544
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of buprenorphine following intravenous and buccal administration in cats, and effects on thermal threshold.
Hedges AR; Pypendop BH; Shilo-Benjamini Y; Stanley SD; Ilkiw JE
J Vet Pharmacol Ther; 2014 Jun; 37(3):252-9. PubMed ID: 24862514
[TBL] [Abstract][Full Text] [Related]
10. Antinociceptive effects of butorphanol, buprenorphine, or both, administered intramuscularly in cats.
Johnson JA; Robertson SA; Pypendop BH
Am J Vet Res; 2007 Jul; 68(7):699-703. PubMed ID: 17605603
[TBL] [Abstract][Full Text] [Related]
11. Buprenorphine in combination with naloxone at a ratio of 15:1 does not enhance antinociception from buprenorphine in healthy cats.
Slingsby LS; Murrell JC; Taylor PM
Vet J; 2012 Jun; 192(3):523-4. PubMed ID: 22030474
[TBL] [Abstract][Full Text] [Related]
12. Plasma concentrations of buprenorphine following a single subcutaneous administration of a sustained release formulation of buprenorphine in sheep.
Zullian C; Lema P; Lavoie M; Dodelet-Devillers A; Beaudry F; Vachon P
Can J Vet Res; 2016 Jul; 80(3):250-3. PubMed ID: 27408341
[TBL] [Abstract][Full Text] [Related]
13. Effects of epidurally administered morphine or buprenorphine on the thermal threshold in cats.
Pypendop BH; Siao KT; Pascoe PJ; Ilkiw JE
Am J Vet Res; 2008 Aug; 69(8):983-7. PubMed ID: 18672960
[TBL] [Abstract][Full Text] [Related]
14. Antinociceptive efficacy and plasma concentrations of transdermal buprenorphine in dogs.
Pieper K; Schuster T; Levionnois O; Matis U; Bergadano A
Vet J; 2011 Mar; 187(3):335-41. PubMed ID: 20206560
[TBL] [Abstract][Full Text] [Related]
15. Antinociceptive effects of intravenous administration of hydromorphone hydrochloride alone or followed by buprenorphine hydrochloride or butorphanol tartrate to healthy conscious cats.
Simon BT; Steagall PV; Monteiro BP; Troncy E; Lizarraga I
Am J Vet Res; 2016 Mar; 77(3):245-51. PubMed ID: 26919594
[TBL] [Abstract][Full Text] [Related]
16. Effects of buprenorphine, carprofen and saline on thermal and mechanical nociceptive thresholds in cats.
Steagall PV; Taylor PM; Brondani JT; Luna SP; Dixon MJ; Ferreira TH
Vet Anaesth Analg; 2007 Sep; 34(5):344-50. PubMed ID: 17490466
[TBL] [Abstract][Full Text] [Related]
17. Low dose naloxone enhances buprenorphine in a tooth pulp antinociceptive assay.
Bergman SA; Wynn RL; Myers DE; Rudo FG
Arch Int Pharmacodyn Ther; 1988; 291():229-37. PubMed ID: 3365064
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the antinociceptive effect of morphine, methadone, buprenorphine and codeine in two substrains of Sprague-Dawley rats.
Bulka A; Kouya PF; Böttiger Y; Svensson JO; Xu XJ; Wiesenfeld-Hallin Z
Eur J Pharmacol; 2004 May; 492(1):27-34. PubMed ID: 15145702
[TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetics and analgesic effects of extended-release buprenorphine administered subcutaneously in healthy dogs.
Barletta M; Ostenkamp SM; Taylor AC; Quandt J; Lascelles BDX; Messenger KM
J Vet Pharmacol Ther; 2018 Aug; 41(4):502-512. PubMed ID: 29521421
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and physiologic/behavioral effects of buprenorphine administered sublingually and intravenously to neonatal foals.
Grubb TL; Kurkowski D; Sellon DC; Seino KK; Coffey T; Davis JL
J Vet Pharmacol Ther; 2019 Jan; 42(1):26-36. PubMed ID: 30242851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
